Search

for
Search:

Learn

0 / 0 results

— no results

Research

5 / 868 results

research Correction to: An Evaluation of the Federal Adverse Events Reporting System Data on Adverse Effects of 5-Alpha Reductase Inhibitors

September 2021 in “World journal of urology”

The correction states that the label change for Finasteride was in 2012, leading to more reports of side effects from non-healthcare people.

Suicidality Risks Associated with Finasteride, a 5-Alpha Reductase Inhibitor: An Evaluation of Real-World Data from the FDA Adverse Event Reports

research Suicidality Risks Associated with Finasteride, a 5-Alpha Reductase Inhibitor: An Evaluation of Real-World Data from the FDA Adverse Event Reports

June 2025 in “Pharmaceuticals”

Finasteride use may increase suicidality risk, especially in young men.

research A Review of the FAERS Data on 5-Alpha Reductase Inhibitors: Implications for Postfinasteride Syndrome

35 citations , June 2018 in “Urology”

The review suggests younger men taking 1 mg finasteride report more side effects, including sexual, skin, metabolic, and psychological issues.

research The Potential Involvement of Cholinergic System in Finasteride Induced Cognitive Dysfunction

November 2020 in “Psychoneuroendocrinology”

Finasteride might affect memory by impacting cholinergic system.

research Safety Profile of Human Papilloma Virus Vaccines: An Analysis of the US Vaccine Adverse Event Reporting System from 2007 to 2017

22 citations , December 2018 in “British Journal of Clinical Pharmacology”

HPV vaccines are generally safe but need further investigation for rare side effects.

View more "federal adverse event reporting system" in research →

Community Join

5 / 21 results

community Why is Finasteride seen as “scary” for men, but hormonal birth control is totally normalized for women?

in Finasteride/Dutasteride 747 upvotes 6 months ago

Finasteride is seen as risky for men due to side effects like erectile dysfunction, while hormonal birth control for women is normalized despite its side effects. The discussion points out a double standard influenced by societal and gender norms.

community Can we all agree that PP405 is now 4 years away

in Chat 96 upvotes 2 months ago

PP405 is expected to be available in 2028, with ongoing discussions about its timeline and potential effectiveness. Current treatments mentioned include sublingual Minoxidil and Vederamicd, with some users experiencing side effects from oral Minoxidil.

community Federal Grant Cuts have impacted PP405 related research

in Technology 458 upvotes 2 months ago

Federal funding cuts have delayed PP405 research, affecting hair loss treatment progress, though clinical trials will continue. The discussion highlights PP405's potential compared to minoxidil and finasteride and stresses the importance of government-funded research.

community Trump halted all federal funding for medical research in the US. Will this affect any current treatments in the pipeline?

in Research/Science 115 upvotes 9 months ago

Federal funding for medical research in the U.S. has been halted, potentially delaying new treatments. Hair loss treatments like finasteride and minoxidil are unlikely to be impacted as they are typically funded by private companies.

community Results of 9 1/2 months of finasteride 1mg daily and 0.5mg dutasteride weekly along with RU58841 daily and microneedling weekly

in Finasteride/Dutasteride 74 upvotes 2 years ago

Finasteride and Dutasteride used in combination with RU58841 and microneedling, as a treatment for hair loss. There was discussion on progress of the treatment and potential other methods to consider.

View more "federal adverse event reporting system" in community →